The present application investigates a new flavor modulating compound having a flavor modulating effect in Korean food which is based on fermentation techniques, and thus shows excellent effects of modulating the flavor of food.

The invention relates to a solid ?.sup.9-THC composition containing ?.sup.9-THC and a powder former and having a molar ratio of ?.sup.9-THC to powder former to form a flowable ?.sup.9-THC powder. The powder former is selected from the group consisting of adenine, aspartame, caffeine, lactose, mannitol, nicotinamide, ?-nicotinamide adenine dinucleotide, pipecolic acid, saccharin, aspartic acid, glutamic acid, glutamine, histidine, leucine, methionine, phenylalanine, proline, serine, tryptophan, valine, Epigallocatechin Gallate (EGCG), 2-Hydroxypropyl-beta-cyclodextrin (HPbCD), and Trimethyl-beta-cyclodextrin (TOMBC) and mixtures thereof. The invention also relates to methods of making a solid ?.sup.9-THC composition of the invention. The ?.sup.9-THC may be synthetic ?.sup.9-THC or may be extracted ?.sup.9-THC. The invention provides pharmaceutical or nutraceutical composition containing a solid ?.sup.9-THC composition of the invention and a pharmaceutically- or nutraceutically-acceptable carrier where ?.sup.9-THC is present in a pharmaceutically or nutraceutically effective amount. The invention also provides methods of treating a disease, disorder, or condition by administering to a patient in need thereof a therapeutically effective amount of a solid ?.sup.9-THC composition. A solid ?.sup.9-THC composition of the invention may also be incorporated into food and beverage products.

A blended sweetener mixture that includes multiple high-intensity sweeteners, optionally combined with one or more bulk sweeteners such as sugar. Combining multiple high-intensity sweeteners creates synergistic effects on taste, while limiting the toxicity from any one ingredient. Mixtures of three or more high-intensity sweeteners may limit the sweetness contribution of any single ingredient to no more than 80% of the total sweetness of the mixture, and limit the sweetness contribution of any two ingredients to no more than 90% of the total sweetness of the mixture. Illustrative high-intensity sweeteners used in embodiments may include for example stevia, sucralose, neotame, and acesulfame potassium; illustrative bulk sweeteners may include for example bulk sugar, bulk powdered or agglomerated sugar, and bulk erythritol. Combinations of multiple high-intensity sweeteners and bulk sweeteners may for example provide effective sugar substitutes with equivalent or greater sweetness, lower calories, and lower glycemic loads.

A solid composition comprising the following components (A) and (B): (A) from 20 to 65 mass % of a fat globule membrane component; and (B) from 0.2 to 4 mass % of a water-soluble dietary fiber having a weight average molecular weight of 10,000 or more.

The invention relates to a solid .sup.9-THC composition containing .sup.9-THC and a powder former and having a molar ratio of .sup.9-THC to powder former to form a flowable .sup.9-THC powder. The powder former is selected from the group consisting of adenine, aspartame, caffeine, lactose, mannitol, nicotinamide, -nicotinamide adenine dinucleotide, pipecolic acid, saccharin, aspartic acid, glutamic acid, glutamine, histidine, leucine, methionine, phenylalanine, proline, serine, tryptophan, valine, Epigallocatechin Gallate (EGCG), 2-Hydroxypropyl-beta-cyclodextrin (HPbCD), and Trimethyl-beta-cyclodextrin (TOMBC) and mixtures thereof. The invention also relates to methods of making a solid .sup.9-THC composition of the invention. The .sup.9-THC may be synthetic .sup.9-THC or may be extracted .sup.9-THC. The invention provides pharmaceutical or nutraceutical composition containing a solid .sup.9-THC composition of the invention and a pharmaceutically- or nutraceutically-acceptable carrier where .sup.9-THC is present in a pharmaceutically or nutraceutically effective amount. The invention also provides methods of treating a disease, disorder, or condition by administering to a patient in need thereof a therapeutically effective amount of a solid .sup.9-THC composition. A solid .sup.9-THC composition of the invention may also be incorporated into food and beverage products.

A solid composition comprising the following components (A) and (B): (A) from 20 to 55 mass % of a fat globule membrane component; and (B) from 0.2 to 4 mass % of a water-soluble dietary fiber having a weight average molecular weight of 10,000 or more.

An encapsulated flavor, comprising a core material, flavor material and a coating material, the core material comprising a finely-divided native starch, xanthan gum and konjac, the combined weight proportion of the xanthan gum and konjac present in the encapsulated flavour being from about 4% to about 16%, and the relative weight proportions of xanthan gum to konjac being from about 20:80 to about 80:20. The encapsulated flavors may be completely gelatin-free, while retaining the desirable qualities of gelatin.

The present invention includes a method for enhancing the taste of a food product, which includes the steps of culturing a submerged mycelial liquid tissue culture in a media, collecting the supernatant fluid of the submerged mycelial liquid tissue culture, and adding the collected supernatant fluid to a food product in an amount sufficient to enhance the food product's taste. In one embodiment, the mycelial liquid tissue culture comprises C. sinensis, and the culture step is carried out for between about one and sixty days. The food products include quinoa, amaranth, whole wheat, stevia plant parts, steviol glycoside, aspartame, acesulfame-K, sucralose, carbohydrates, salt substitutes such as potassium chloride, monk fruit, cacao, cacao liquor, tea, ginseng, pea protein, sugar alcohol, coffee, cranberry, grapefruit, pomegranate, coconut, wine, beer, liquor and spirits. The present invention also includes products made by the disclosed methods.

Glucosyl Stevia compositions are prepared from steviol glycosides of Stevia rebaudiana Bertoni. The glucosylation was performed by cyclodextrin glucanotransferase using the starch as source of glucose residues. The compositions mainly comprise glucosyl derivatives with superior taste characteristics and can be used as sweetness enhancers, flavor enhancers and sweeteners in foods, beverages, cosmetics and pharmaceuticals.

The use of glucopyranoside compounds to enhance the sweetness of a sweetness modifier and to decrease the amount of a sweetness modifier used in a consumable is provided.